FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

11143611000001102: Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40024101000001110 Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42044301000001115 Ondansetron 4mg tablets (PLIVA Pharma Ltd) 10 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Is a Ondansetron 4mg tablets 10 tablet true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Is pack of Ondansetron 4mg tablets (Pliva Pharma Ltd) false Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has active ingredient Ondansetron hydrochloride false Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has active ingredient Ondansetron false Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has AMP Ondansetron 4mg tablets (Pliva Pharma Ltd) true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has specific active ingredient Ondansetron hydrochloride true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Ondansetron 4mg tablets (Pliva Pharma Ltd) 10 tablet Has basis of strength substance Ondansetron true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start